content

DefiniGEN Launches Tool for Coronavirus-Specific Intestinal Cell Research

DefiniGEN has identified iPSC-derived intestinal organoids that could be used to help structure in vitro studies of the biology of SARS-CoV2 infection across cohorts...

Leinco Announces Development of Immunodiagnostic Test for COVID-19

Leinco Technologies announced an agreement with Vanderbilt University Medical Center (VUMC) to scale up production of its most promising antibodies for development of a...

Cellect Biotechnologys ApoGraft to Empower Cellular Treatment of COVID-19 Related Pulmonary Diseases

Cellect Biotechnology Ltd., a developer of innovative technology which enables the functional selection of stem cells, announced that it has signed a development agreement...

Kindred Biosciences Announces COVID-19 Vaccine Manufacturing Agreement with Vaxart

Kindred Biosciences, Inc., a biopharmaceutical company developing novel biologics, announced it has entered into an agreement with Vaxart, Inc. for the manufacture of Vaxart's...

DHL Global Forwarding launches innovative one-stop customer portal for digital logistics

DHL Global Forwarding, Deutsche Post DHL Groupโ€™s air and ocean freight specialist, has launched myDHLi, the only fully integrated online platform for freight forwarding...

DTx Pharma Expands Footprint in San Diego with New Office and Lab Space

DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease, announced the expansion of its...

WuXi Biologics Closes Land Deal to Build State-of-the-Art Biologics Production Facility in the United States

WuXi Biologics, a global company with leading open-access biologics technology platforms, and the Worcester Business Development Corporation (WBDC) announced the successful signing of a...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read